Table 2 Characteristics of the study group according to genotype distribution.
| Genotype distribution | Patients with stroke (n = 108) | Controls (n = 216) | Crude OR | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|
| Methylenetetrahydrofolate reductase C677T | ||||||||
| CC | 25 (23.1) | 84 (38.9) | 1 | |||||
| CT | 61 (56.5) | 110 (50.9) | 1.86 | 1.00 to 3.21 | ||||
| TT | 22 (20.4) | 22 (10.2) | 3.36 | 1.60 to 7.05 | ||||
| FV G1691A | ||||||||
| GG | 103 (95.3) | 210 (97.2) | 1 | |||||
| GA | 5 (4.7) | 6 (2.8) | 1.70 | 0.51 to 5.70 | ||||
| AA | 0 (0.0) | 0 (0.0) | – | |||||
| PT G20210A | ||||||||
| GG | 98 (90.7) | 213 (98.6) | 1 | |||||
| GA | 9 (8.4) | 3 (1.4) | 6.52 | 1.73 to 24.6 | ||||
| AA | 1 (0.9) | 0 (0.0) | – | |||||
| FV 1691A or PT 20210A or TT MTHFR | ||||||||
| No | 75 (69.4) | 185 (85.6) | 1 | |||||
| Yes | 33 (30.6) | 31 (14.4) | 2.63 | 1.50 to 4.59 | ||||